133 related articles for article (PubMed ID: 26261595)
1. Significance of TLR4/MyD88 expression in breast cancer.
Chen X; Zhao F; Zhang H; Zhu Y; Wu K; Tan G
Int J Clin Exp Pathol; 2015; 8(6):7034-9. PubMed ID: 26261595
[TBL] [Abstract][Full Text] [Related]
2. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.
Wu K; Zhang H; Fu Y; Zhu Y; Kong L; Chen L; Zhao F; Yu L; Chen X
Mol Med Rep; 2018 Sep; 18(3):3411-3420. PubMed ID: 30066873
[TBL] [Abstract][Full Text] [Related]
3. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Ma FJ; Liu ZB; Hu X; Ling H; Li S; Wu J; Shao ZM
PLoS One; 2014; 9(10):e111639. PubMed ID: 25360699
[TBL] [Abstract][Full Text] [Related]
5. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
6. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of PD-L1 and PD-L2 in breast cancer.
Baptista MZ; Sarian LO; Derchain SF; Pinto GA; Vassallo J
Hum Pathol; 2016 Jan; 47(1):78-84. PubMed ID: 26541326
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers.
Kim KH; Jo MS; Suh DS; Yoon MS; Shin DH; Lee JH; Choi KU
World J Surg Oncol; 2012 Sep; 10():193. PubMed ID: 22985132
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.
Yang H; Wang B; Wang T; Xu L; He C; Wen H; Yan J; Su H; Zhu X
PLoS One; 2014; 9(10):e109980. PubMed ID: 25299052
[TBL] [Abstract][Full Text] [Related]
13. [Significance of chemokine receptor CXCR3 expression in breast cancer].
Li L; Chen J; Lu ZH; Yu SN; Luo YF; Zhao WG; Ma YH; Jia CW
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):85-8. PubMed ID: 21426802
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract][Full Text] [Related]
15. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
17. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.
González-Reyes S; Marín L; González L; González LO; del Casar JM; Lamelas ML; González-Quintana JM; Vizoso FJ
BMC Cancer; 2010 Dec; 10():665. PubMed ID: 21129170
[TBL] [Abstract][Full Text] [Related]
18. TLR4 mRNA levels as tools to estimate risk for early posttransplantation kidney graft dysfunction.
Andrade-Oliveira V; Campos EF; Goncalves-Primo A; Grenzi PC; Medina-Pestana JO; Tedesco-Silva H; Gerbase-DeLima M
Transplantation; 2012 Sep; 94(6):589-95. PubMed ID: 22892989
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal expression of RSK-4 and its clinical significance in breast cancer].
Liu JL; Yang HW; Chen ZS; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487
[TBL] [Abstract][Full Text] [Related]
20. [The expression and significance of TLR4, MyD88 and NF-κB mRNA in mouse lymph node of experimental autoimmune myositis].
Zhang HY; Kang J; Han WJ; Hu MM; Jia HG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):272-5. PubMed ID: 22394636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
